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In Brief
T cell migration through afferent
lymphatic vessels contributes to immune
surveillance, but the cellular mechanisms
of this process are largely unknown.
Using intravital microscopy, Teijeira et al.
show that T cells crawl in an ICAM-1/LFA-
1-dependent manner within inflamed
dermal lymphatic capillaries but only flow
with lymph once in contracting collectors.
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T cells are the most abundant cell type found in
afferent lymph, but their migration through lymphatic
vessels (LVs) remains poorly understood. Performing
intravital microscopy in the murine skin, we imaged
T cell migration through afferent LVs in vivo. T cells
entered into and actively migrated within lymphatic
capillaries but were passively transported in con-
tractile collecting vessels. Intralymphatic T cell num-
ber andmotilitywere increasedduring contact-hyper-
sensitivity-induced inflammation and dependent on
ICAM-1/LFA-1 interactions. Invitro,blockadeofendo-
thelial cell-expressed ICAM-1 reduced T cell adhe-
sion, crawling, and transmigration across lymphatic
endothelium and decreased T cell advancement
from capillaries into lymphatic collectors in skin ex-
plants. In vivo, T cell migration to draining lymph no-
des was significantly reduced upon ICAM-1 or LFA-1
blockade. Our findings indicate that T cell migration
through LVs occurs in distinct steps and reveal a key
role for ICAM-1/LFA-1 interactions in this process.INTRODUCTION
Afferent lymphatic vessels (LVs) fulfill important immune func-
tions by transporting soluble antigen and leukocytes such as
dendritic cells (DCs) or recirculating T cells to draining lymph no-
des (dLNs). T cells represent the major leukocyte cell type found
in steady-state afferent lymph (Mackay et al., 1990; Young,
1999), and their migration through peripheral tissues and into
afferent LVs is thought to contribute to immune surveillance.
Most T cells found in afferent lymph of sheep and humans display
a memory phenotype, with CD4+ T cells outnumbering CD8+
T cells by 4- to 5-fold (Mackay et al., 1990; Yawalkar et al.,Cell
This is an open access article under the CC BY-N2000). The factors that determine T cell residence as compared
to tissue egress into afferent LVs are not completely clear, but
various studies have demonstrated that the CCR7/CCL21
pathway (Bromley et al., 2013; Debes et al., 2005) and sphingo-
sine-1-phosphate (S1P) (Brown et al., 2010; Ledgerwood et al.,
2008) play a pivotal role in this process. Recently, the phenotype
of recirculating memory CD4+ T cells (TRCM) was described as
CCR7int/+CD62LintCD69CD103+/CCR4+/E-selectin ligand+.
TRCM were shown to migrate from skin to dLNs and from there
back into circulation and to sites of cutaneous inflammation
(Bromley et al., 2013).
Intravitalmicroscopy (IVM)has recently shed light on themotility
of individual T cells in peripheral tissues like the skin. In particular,
IVM studies have revealed that under inflammatory conditions,
bothCD4+ andCD8+ effector T cells activelymigrate in the dermis
(Egawaetal., 2011).Conversely, in thememoryphase followingan
antiviral immune response, CD8+ cells were shown to remain ar-
rested in the epidermis, whereas CD4+ memory cells avidly
migrated through the dermis (Gebhardt et al., 2011). In contrast
to interstitial migration, T cell entry into afferent LVs and tissue
exit has thus far not been investigated by IVM. In this study, we
describe amousemodel that allows for simultaneous visualization
of endogenous T cells and LVs by IVM. Using this model, we
observed that T cells migrate in a semi-directed manner within
afferent lymphatic capillaries and are carried away by flow once
they have reached downstream collecting vessels. Moreover,
we demonstrate that during inflammation, intralymphatic T cell
crawling and migration to dLNs depend on ICAM-1 and LFA-1.
RESULTS
Characterization of the Mouse Model
To visualize T cell migration within LVs, we crossed Prox1-GFP
mice, which expressGFPunder the control of the lymphatic-spe-
cific Prox1 promoter (Choi et al., 2011), with mice expressing a
red fluorescent protein (DsRed) in all T cells, under the control
of a human CD2 promoter (Veiga-Fernandes et al., 2007). TheReports 18, 857–865, January 24, 2017 ª 2016 The Author(s). 857
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Characterization of hCD2-DsRedxProx1-GFP Mouse Model
(A and B) FACS analysis was performed on single-cell suspensions of steady-state or CHS-inflamed ear skin. (A) Left: representative FACS plots of steady-state
ear skin showing CD4 and CD8 expression in the DsRedhi population. Right: analysis of the percentage of CD4+, CD8+, CD4+CD8+, and CD4CD8 among all
live, DsRedhiCD45+ cells in spleen (Spl), LNs (popliteal, inguinal, and brachial pooled) or ear skin under steady-state or CHS-inflamed conditions. Mean ± SEM is
shown. (B) Most dermal CD4+DsRedhi T cells express a memory phenotype. Data from three to seven similar experiments are shown.
(C and D) Representative images taken from IVM performed in (C) steady-state or (D) CHS-inflamed ear skin (scale bar, 50 mm).
(E–H) Time-lapse images showing T cell (E) intravasation (scale bar, 15 mm), (F) intralymphatic crawling (same cell marked with an asterisk; scale bar, 20 mm), and
free flow in afferent (G) or efferent collectors (H) (scale bar, 100 mm).
(I) Model of T cell migration through afferent LVs.resulting hCD2-DsRedxProx1-GFP mice feature red T cells and
green lymphatics (Figure S1A). Flow cytometry revealed that
CD4+ and CD8+ T cells accounted for 90% of all DsRedhi cells
in the ear skin, lymph nodes (LNs), and spleen of thesemice (Fig-
ures 1A and S1B). While in LNs and spleen most DsRedhiCD4+858 Cell Reports 18, 857–865, January 24, 2017T cells were naive (CD44lowCD45RBhigh), they mainly displayed
an effector-memory phenotype in the skin (CD44hiCD45RBlo;
Figure 1B). In intravital confocal imaging performed in murine
ear skin, bothGFP+ LVs andDsRedhi T cellswere brightly fluores-
cent (Figure 1C). To image under inflammatory conditions, we
Figure 2. Inflammation Enhances T Cell Motility in the Interstitium
and within Lymphatic Capillaries
IVM was performed in the ear skin under steady-state or CHS-inflamed con-
ditions and the speed (A), chemotactic index (B), and motility coefficient (C) of
T cells in the interstitium and within LVs were analyzed. Each dot represents a
tracked cell. Pooled data from four mice per condition are shown.elicited a contact hypersensitivity (CHS) response toward oxazo-
lone. This led to a striking increase in the number of intra- and
extravascular DsRedhi T cells (Figure 1D). Also in inflamed skin,
DsRedhi cells were mainly CD8+ and CD4+ T cells displaying an
effector-memory phenotype (Figures 1A and 1B). Inflammation
also induced the recruitment of a population of DsRedlo cells
into the skin (Figure S1C). DsRedlo cells displayed a larger side
scatter (SSC-A) and were negative for CD3, CD11c, and Ly6G
but positive for CD11b and NK1.1 (Figure S1C), suggesting that
these were natural killer (NK) cells. To investigate the localization
and movement of DsRedhi and CD11b+DsRedlo cells in inflamed
ear skin, we performed time-lapse imaging upon injection of an
Alexa-Fluor-647-labeled anti-CD11b antibody. This revealed
that CD11b+DsRedlo cells preferentially localized around hair fol-
licles (Figure S1D). Only a fewCD11b+DsRedlo cells weremoving
in the interstitium, with a markedly reduced motility compared to
DsRedhi cells (Movie S1; Figure S1E). Moreover, 36 hr after onset
of inflammation, virtually no DsRedloCD11b+ cells had migrated
to dLNs in fluorescein isothiocyanate (FITC) painting experiments
(Figures S1F and S1G). In fact, all cells detected within LVs were
DsRedhi, whereas no intralymphatic CD11b+DsRedlo cells were
observed (Movies S2 and S3; data not shown). Therefore, only
DsRedhi cells were considered T cells and included in our further
analyses.
T Cells Crawl within Lymphatic Capillaries and Flow
within Lymphatic Collectors
We next imaged intravasation of DsRedhi T cells into LVs in
CHS-inflamed ear skin (Figure 1E; Movie S4). T cell intravasation
preferentially occurred in areas close to the blind ends of
lymphatic capillaries, as described for DCs (Pflicke and Sixt,
2009). Once within dermal lymphatic capillaries, T cells moved
by active crawling, as previously described for intralymphatic
DCs (Nitschké et al., 2012;Russoet al., 2016; Tal et al., 2011) (Fig-
ure 1F; Movies S2 and S3). To visualize the behavior of T cells
within lymphatic collectors, we imaged near the base of the ear
pinnae, where mostly collector vessels are present. Here, we
observed T cells crawling in lymphatic segments and subse-
quently getting detached and passively drawn into the collector
upon collector pumping (Figure 1G; Movie S5). Using faster
acquisition settings, we observed T cells flowing within pumping
afferent LVs in the ear (Movie S6). To further visualize T cells in
efferent LVs, we imaged the efferent LV leaving the inguinal LN
by stereomicroscopy. In this large collector, the passive move-
ment of T cells was synchronized with the pumping of the collec-
tor, and the valves largely impededback flowof Tcells (Figure 1H;
MovieS7). TheaverageTcell speedwas180mm/s, but peak ve-
locities of up to1mm/swere reached in the valve regions.Overall,
these experiments revealed that T cell migration to dLNs involves
entry at the level of the lymphatic capillaries, active crawling and
patrolling within capillaries, and passive flow once the cells reach
contracting collecting vessels (Figure 1I).
Inflammation Increases T Cell Motility within LVs
In agreement with previous IVM studies (Overstreet et al., 2013),
interstitial T cell motility in steady state was rather low (Figures
2A–2C; Movie S2). T cells in the initial lymphatic capillaries also
displayed low motility (Figures 2A–2C; Movie S2). Interestingly,Cell Reports 18, 857–865, January 24, 2017 859
Figure 3. Increased Motility of T Cells within LVs Is ICAM-1 Dependent
(A and B) FACS analysis was performed on mouse ear skin single-cell suspensions. ICAM-1 expression was analyzed in LECs derived from lymphatic capillaries
(CD45CD31+podoplanin+LYVE-1+; green) or from lymphatic collectors (CD45CD31+podoplanin+LYVE-1; blue). (A) Gating scheme. (B) Left: representative
FACS plots of ICAM-1 expression in LECs derived from capillaries (Cap; green) and collectors (Coll; blue); Corresponding isotypes are shown (isotype; gray).
(legend continued on next page)
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in CHS-induced tissue inflammation, the motility of DsRedhi
T cells increased in the interstitium and even more so within
lymphatic capillaries (Figures 2A–2C; Movie S3). Increases
in T cell motility appeared to be a consequence of tissue
inflammation, since it was also observed in inflammation
induced by injection of complete Freund’s adjuvant (CFA) (Fig-
ures S2A–S2C).
TCell Motility within Lymphatic Vessels of InflamedSkin
Is ICAM-1 and LFA-1 Dependent
We and others have previously shown that ICAM-1 is upregu-
lated in LVs during CHS- and CFA-induced skin inflammation
(Johnson et al., 2006; Vigl et al., 2011). This prompted us to
investigate whether ICAM-1 was involved in the increase in intra-
lymphatic T cell motility observed in the context of inflamma-
tion. Interestingly, we found that ICAM-1 levels were consistently
higher in lymphatic endothelial cells (LECs) derived from
lymphatic capillaries than in LECs derived from collecting ves-
sels and thus in the vessel segment in which T cells and DCs
move by active crawling (Figures 3A and 3B). Since ICAM-1 me-
diates T cell crawling on blood vascular endothelium (Shulman
et al., 2009; Steiner et al., 2010), we next investigated whether
ICAM-1 blockade would affect T cell crawling within inflamed
lymphatic capillaries. While no change in themotility of interstitial
T cells was observed upon ICAM-1 blockade, the speed and
motility coefficient of intralymphatic T cells were reduced to
values previously measured in uninflamed, steady-state condi-
tions (Figures 3C, 3D, and 2A, and 2B). We also noticed that
T cells migrating within LVs in CHS-inflamed ears displayed
the characteristic shape of a cell migrating in an integrin
dependent fashion, i.e., an evident uropod and a leading edge
(Figure 3E). In contrast, intralymphatic T cells in non-inflamed
ears or upon ICAM-1 blockade, displayed amore rounded shape
(Figures 3E and 3F). Further IVM experiments revealed that
blockade of LFA-1 (i.e., the T cell-expressed ligand of ICAM-1)
resulted in a comparable reduction of intralymphatic T cell crawl-
ing, suggesting the requirement of ICAM-1/LFA-1 interactions in
this process (Figures 3G and 3H).
To investigate whether ICAM-1 blockade would impact the
overall ability of T cells to advance through the lymphatic
network, we performed experiments with in vitro Th1-polarized
DsRed+ effector T cells (Gómez et al., 2015) (Figures S3A–S3C)
in ear skin explants of Prox1-GFP mice. In our setup, Th1 cells
were added on the peripheral ear skin region of the explant
and left to enter into the underlying lymphatic capillaries in pres-
ence of anti-ICAM-1 or control immunoglobulin G (IgG). When
analyzing the more centrally located collecting vessels 24 hr
later, we consistently detected fewer T cells within collectorsRight: summary of the delta median fluorescent intensities (DMFIs; difference in
staining), measured in four independent experiments.
(C and D) IVM was performed in CHS-inflamed ear skin upon treatment with an
coefficient (D) of interstitial and intralymphatic DsRedhi T cells. Each dot represe
(E) Representative images of cells shapes of T cells migrating within LVs in stead
isotype control antibody.
(F) Quantification of the cell diameter ratio (length/width). Pooled data from three
(G and H) Further IVM was performed in CHS-inflamed ear skin upon treatment wi
coefficient (H) of interstitial and intralymphatic DsRedhi T cells. Each dot represeof anti-ICAM-1-treated as compared to control-treated explants,
suggesting that ICAM-1 blockade had interfered with T cell
advancement from their point of entry at the level of the
lymphatic capillaries into the collectors (Figures S3D–S3H).
ICAM-1 Blockade Impairs T Cell Crawling, Adhesion,
and Transmigration In Vitro
To further validate our findings, we established an in vitro assay
system involving Th1 cells and conditionally immortalizedmurine
LECs (imLECs) (Vigl et al., 2011) (Figures S3A–S3C and S4A).
Also in vitro, Th1 cell motility on lymphatic endothelium was
significantly reduced upon ICAM-1 blockade (Figures 4A and
4B). Surprisingly, T cells crawled equally fast on resting and on
tumor necrosis factor alpha/interferon gamma (TNF-a/IFN-g)-
treated imLEC monolayers, likely because imLECs, in contrast
to LECs in the skin, already express high levels of ICAM-1 under
resting conditions (Figure S4A). Although TNF-a/IFN-g treatment
induced a strong upregulation of VCAM-1 in imLECs (Fig-
ure S4A), VCAM-1 blockade did not further reduce the speed
of T cell crawling under inflammatory conditions (Figures S4B
and S4C). Similarly, IVM performed in the presence of VCAM-1
blocking antibody (6C7.1) did not reveal any contribution of
VCAM-1 to intralymphatic crawling (Figure S4F).
ICAM-1 reportedly mediates leukocyte extravasation from
blood vessels (Shulman et al., 2009; Steiner et al., 2010) as
well as DC migration through LVs (Johnson et al., 2006; Tei-
jeira et al., 2013). We therefore next investigated whether
ICAM-1 also promoted effector T cell adhesion and transmi-
gration across lymphatic endothelium. Under control condi-
tions, ICAM-1 blockade strongly inhibited T cell adhesion (Fig-
ure 4C). By contrast, under TNF-a/IFN-g-treated conditions,
when VCAM-1 was highly upregulated (Figure S4A), combined
ICAM-1/VCAM-1 blockade was needed to profoundly inhibit
T cell adhesion to LECs (Figure 4C). Conversely, in in vitro
transmigration assays, ICAM-1 blockade equally inhibited
Th1 transmigration across resting or TNF-a/IFN-g-treated
imLEC monolayers (Figure 4D), without any further contribu-
tion of VCAM-1 to the transmigration process (Figures S4D
and S4E).
ICAM-1 or LFA-1 Blockade Reduces T Cell Migration
from Inflamed Skin to dLNs
Finally, we assessed the overall relevance of ICAM-1 in in vivo
T cell migration through afferent LVs to dLNs. For this, we co-in-
jected activated T cells and ICAM-1 blocking or control antibody
into CHS-inflamed ear skin and quantified T cell numbers in the
dLN 18 hr later. In this setup ICAM-1 blockade significantly
reduced T cell migration to the dLN (Figures 4E and 4F). Similarly,the median fluorescent intensity between the specific and the isotope control
ti-ICAM-1 or isotype control antibody. Analysis of the speed (C) and motility
nts a tracked cell. Pooled data from three mice per condition are shown.
y-state ear skin or in CHS-inflamed ear skin treated with ICAM-1-blocking or
experiments are shown. Mean ± SEM is shown.
th anti-LFA-1 or isotype control antibody. Analysis of the speed (G) and motility
nts a tracked cell. Pooled data from three mice per condition are shown.
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Figure 4. ICAM-1 Mediates In Vitro Interactions between T Cells and Lymphatic Endothelium, as Well as In Vivo Migration of T Cells to dLNs
(A–D) DsRed+ Th1 cells were placed onto control-treated or IFNg/TNFa-treated imLEC monolayers and the impact of anti-ICAM-1 or isotype IgG on T cell
crawling, adhesion, and transmigration was analyzed. Blockade of ICAM-1 reduced the speed (A), and motility coefficient (B) of T cell crawling on lymphatic
endothelium. Each dot represents a tracked cell. Data from one out of three similar experiments is shown. (C) Blockade of ICAM-1 or of ICAM-1 and VCAM-1
(referred as 6C7.1) reduced the T cell adhesion to imLEC monolayers. Data from one out of four similar experiments are shown. (D) ICAM-1 blockade reduced
T cell transmigration across imLEC monolayers. Pooled data from three similar experiments are shown. Mean ± SEM is shown.
(E–H) Activated T cells were injected into CHS-inflamed ear skin in the presence of ICAM-1-blocking (E and F) or LFA-1-blocking (G and H) antibody or the
respective control antibody. 18 hr later, T cell numbers were quantified in auricular dLNs by FACS. Absolute number (E and G) and percentage (F and H) of
transferred T cells among total LN cells. Each dot represents an individual mouse. Data from one representative experiment out of two or three similar exper-
iments are shown. Mean ± SEM is shown.blockade of LFA-1 significantly reduced the number of adop-
tively transferred T cells that migrated to the dLN (Figures
4G and 4H). Overall, these findings demonstrate a key role
for ICAM-1/LFA-1 interactions in T cell migration through
afferent LVs.862 Cell Reports 18, 857–865, January 24, 2017DISCUSSION
In this study, we imaged T cell migration into and within dermal
LVs. In contrast to T cell extravasation from blood vessels or
migration within the skin, this process is far less well understood,
at both the molecular and cellular levels. Our results show that
T cell migration through afferent LVs occurs in a stepwise
fashion; T cells that have entered into afferent capillaries first
crawl in a semi-directed manner toward lymphatic collectors,
from where they are passively transported within the lymph fluid
to the dLN. This multistep process recapitulates the multistep
migration pattern that we and others recently described for DC
migration through afferent lymphatics (Nitschké et al., 2012;
Russo et al., 2016; Tal et al., 2011). The reason why DCs and
T cells need to actively crawl within afferent capillaries probably
lies in the weak lymph flow conditions within these vessels
segments. Most likely, only the pumping lymphatic collectors
generate sufficient flow and shear to support passive transport
of leukocytes at high speed within lymph fluid. However, given
that anesthesia is expected to slow down lymph flow, T cell
speeds measured in collectors of anesthetized animals may be
an underestimation of T cell speeds in collectors of awake
animals. In agreement with our previous findings on DC migra-
tion (Russo et al., 2016), T cells do not migrate unidirectionally
through capillaries but display an intralymphatic patrolling
behavior. Whether this intralymphatic movement is indeed
semi-directed, and as in the case of DCs, dependent on an intra-
lymphatic CCL21 gradient (Russo et al., 2016) remains to be
investigated.
Under steady-state conditions, we typically observed only few
T cells in the interstitium or within afferent capillaries and collec-
tors. Given that most dermal T cells display an effector-memory
phenotype, this low cell numbermost likely represents an artifact
of the hygienic mouse housing conditions of laboratory mice, in
which abnormally few effector-memory cells populate peripheral
tissues (Beura et al., 2016). It is therefore very likely that under
less hygienic, more natural conditions, many more T cells are
present within afferent lymphatics in steady state. By contrast,
under inflammatory conditions, high numbers of T cells are re-
cruited into the skin and into afferent LVs. This is consistent
with afferent lymph cannulation studies in sheep reporting a
dramatic increase in T cell entering the afferent lymph during
inflammation (Brown et al., 2010). Our data show that the striking
increase in intralymphatic crawling velocity observed in vivo in
the context of inflammation wasmainly due to ICAM-1 upregula-
tion in LECs; blockade of ICAM-1 or its T cell-expressed ligand,
LFA-1, reduced crawling velocities to values observed under
steady-state conditions, during which LECs express low levels
of ICAM-1. Besides mediating intralymphatic crawling, ICAM-1
also supported T cell adhesion and transmigration across LEC
monolayers and, most importantly, the overall process of T cell
migration to dLNs. Notably, we observed the contribution of
ICAM-1 to T cell migration to dLNs under inflammatory condi-
tions, but not under steady-state conditions (data not shown),
likely because of the low ICAM-1 levels expressed on LVs in
the absence of inflammation. Our observations are in agreement
with previous findings on DCs, which migrate integrin indepen-
dently into lymphatics and to dLNs in steady state (Lämmermann
et al., 2008), whereas in inflammation, integrins and their LEC-
expressed ligands start to play a key role in migration (Johnson
et al., 2006; Johnson and Jackson, 2010; Teijeira et al., 2013).
In agreement with our in vitro findings, we did not observe any
effect of VCAM-1 blockade on in vivo T cell crawling within cap-illaries (Figures S4F and S4G). However, blockade of VCAM-1
strongly reduced the overall ability of T cells to migrate from in-
flamed skin to the dLN (Figures S4G and S4H). Although not
experimentally addressed in this study, these findings point to-
ward an involvement of VCAM-1 in T cell entry into LVs in vivo.
In support of such an involvement, we observed that combined
blockade of VCAM-1 and ICAM-1 further reduced in vitro Th1
cell adhesion to lymphatic endothelium when compared to
ICAM-1 blockade alone (Figure 4C). However this experiment
did not address the contribution of VCAM-1alone to in vitro adhe-
sion. The reason why VCAM-1 blockade did not result in a defect
in in vitro transmigration (Figures S4D and S4E) could be linked
with the fact that in-vitro-generated Th1 cells expressed rather
low levels of the a4 integrin subunit CD49d, which forms part of
the VCAM-1-binding VLA-4 integrin (Figure S3C). Additionally,
in-vitro-cultured imLECs express very high ICAM-1 levels (Fig-
ure S4A), whichmight have overridden any potential contribution
of VCAM-1 in the transmigration process.
Overall, our data reveal that LFA-1/ICAM-1 interactions are not
only important for directing T cells out of blood vessels into pe-
ripheral tissues but also facilitate T cell tissue egress and recircu-
lation during inflammation. These findings somewhat differ from
those recently reported for T cell egress from LNs; here, LFA-1
and ICAM-1 were shown to prevent T cell transmigration across
lymphatic sinuses into efferent lymphatics, thereby contributing
to a longer T cell dwell time within the LN (Reichardt et al., 2013).
The reason for these differences between the roles of LFA-1/
ICAM-1 in T cell migration into afferent versus efferent lym-
phatics is not clear, but it could be related to the different func-
tions and localization of the tissue egress and retention signals
S1P and CCL21 in LNs and skin. In inflammatory and malignant
conditions, tissue egress of T cells most likely takes place almost
exclusively via afferent LVs. Given that the molecular players in
LV entry and crawling are very similar to those involved in tissue
entry from blood vessels, these mechanisms are very difficult to
dissect from a therapeutic point of view. It is likely that approved
drugs such as fingolimod (a functional antagonist of S1P recep-
tors) or natalizumab (a monoclonal antibody blocking a4 integrin
subunits) not only affect entry but also exit of T cells from in-
flamed tissues. Thus far, only two lymphatic endothelial cell-ex-
pressed adhesion molecules mediating T cell migration through
afferent LVs have been identified, namely CLEVER-1 (Karikoski
et al., 2009) and the macrophage mannose receptor (Salmi
et al., 2013). Overall, our study contributes to understanding
the molecular control of T cell migration into afferent lymphatics
and adds insight on how this process occurs at the cellular level.EXPERIMENTAL PROCEDURES
Mouse Strains
Wild-type (WT) C57BL/6 mice were purchased from Janvier. Prox1-GFP mice
(Choi et al., 2011) and hCD2-DsRed mice (Veiga-Fernandes et al., 2007) were
bred in our facility. All experiments were approved by the Cantonal Veterinary
Office Zurich.
Flow Cytometry
Flow cytometry was performed on ear skin, LNs, spleen, or in-vitro-gener-
ated Th1 cells from CD2-DsRed or WT mice. Ear skin was digested with colla-
genase IV (Invitrogen) as previously described (Vigl et al., 2011). Single-cellCell Reports 18, 857–865, January 24, 2017 863
suspensions were stained as specified in Supplemental Experimental Proced-
ures. Fluorescence-activated cell sorting (FACS) analysis was performed on a
BD FACSCanto (BD Biosciences) using FACSDiva software. Data were
analyzed offline using FlowJo software 10.0.1 (Tree Star).
IVM Specifications and Treatment Conditions
IVM on the dorsal side of the mouse ear pinna of anesthetized hCD2-
DsRedxProx1-GFP mice was performed as previously described (Nitschké
et al., 2012; Russo et al., 2016). The exact IVM specifications, treatment con-
ditions, and specifications for T cell motility analysis are provided in Supple-
mental Experimental Procedures.
CHS-Induced Ear Skin Inflammation
A CHS response toward oxazolone was induced as described previously
(Vigl et al., 2011). Briefly, mice were anesthetized and sensitized by topical
application of 2% oxazolone (4-ethoxymethylene-2-phenyl-2-oxazoline-
5-one; Sigma) in acetone/olive oil (4:1 vol/vol) on the shaved abdomen
(50 mL) and on each paw (5 mL). 5 days later, 10 mL of a 1% oxazolone solution
was applied topically to each side of the ears (challenge phase). Experiments
were performed 24 hr after challenge.
Adoptive Transfer Experiment
CD4+ cells were purified from the spleens of OTII mice using CD4 (L3T4)
microbeads (Miltenyi Biotec). CD4+ T cells were activated for 48 hr with
100 ng/mL OVA323–339 peptide. After an additional 24 hr without peptide, cells
were labeled with CFSE (Sigma) according to the manufacturer’s instructions.
106 cells, together with 5 mg anti-mouse ICAM-1 antibody (clone YN1/1.7.4;
BioLegend), anti-mouse LFA-1 antibody (clone M17/4; BioXCell), anti-mouse
VCAM-1 (6C7.1; Engelhardt et al., 1998), or corresponding isotypes (from
BioLegend or BioXCell), in 10 mL were co-injected into the dorsal half of
CHS-inflamed ears of WT mice. 18 hr later, auricular LNs were harvested,
stained with CD4-APC (BioLegend), and analyzed on a FACSCalibur (BD Bio-
sciences). Counting beads were added to determine absolute cell numbers.
Generation of Th1 Cells
CD4+ cells were isolated from LNs and spleen of hCD2-DsRedmice and differ-
entiated into Th1 cells in vitro as described previously (Gómez et al., 2015) and
in Supplemental Experimental Procedures.
In Vitro Experiments with Murine LECs and Th1 Cells
For details, see Supplemental Experimental Procedures.
Statistical Analysis
All cell-tracking data are presented as medians, and all other results are pre-
sented as mean plus SEM. Datasets were analyzed with Prism 6 (GraphPad).
Kruskal-Wallis test followed by post hoc analysis was used for multiple com-
parisons and Mann-Whitney U test for simple comparisons.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and seven movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.12.078.
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